Berbice Capital Management LLC Takes $26,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Berbice Capital Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 50 shares of the medical equipment provider’s stock, valued at approximately $26,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $36,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the third quarter worth approximately $38,000. Finally, DT Investment Partners LLC lifted its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Royal Bank of Canada boosted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday. Finally, JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $563.67.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $582.25 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business has a 50-day moving average of $544.61 and a two-hundred day moving average of $502.64. The stock has a market capitalization of $207.38 billion, a P/E ratio of 93.06, a P/E/G ratio of 5.19 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock worth $22,070,807 over the last three months. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.